# Pyxis Oncology, Inc.: Form DEF 14A, filed Apr 26, 2024

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: DEF 14A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 16:15 ET
- Period: 2024-06-11
- Accession: 0000950170-24-049154
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000095017024049154/2024_pyxs-14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000095017024049154/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000095017024049154/2024_pyxs-14a.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-049154. Last ingested by Listed: Nov 3, 2026, 10:04 ET. No prices; not investment advice.